Publications by authors named "Georgia Li"

Claim this Profile
T
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis.
Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li

Hepatol Commun· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Stephen A Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, Natalie Bzowej, Raj Vuppalanchi, Anita Kohli, Georgia Li

J Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Zobair M Younossi, Maria Stepanova, Quentin M Anstee, Eric J Lawitz, Vincent Wai-Sun Wong, Georgia Li

Clin Gastroenterol Hepatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Quentin M Anstee, Eric J Lawitz, Naim Alkhouri, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Georgia Li, Ling Han, Anita Kohli, Natalie Bzowej

Hepatology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen Caldwell, Mitchell L Shiffman, Andrew N Billin, Georgia Li

Hepatology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Nicholas J Gaspar, Lingyun Li, Ann M Kapoun, Satyanarayana Medicherla, Mamatha Reddy, Georgia Li, Alison Murphy, Linda S Higgins

Mol Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis